Market Research Report

Product code

1044144

The World Liquid Biopsy Market 2021

Published: December 28, 2021 |

Kalorama Information | 228 Pages | Delivery time: 1-2 business days

Price

Description
Table of Contents

Add to Compare

This report, “The World Liquid Biopsy Market, 2021 ”, from Kalorama Information, contains up-to-date information and useful data points for business planning:

Research vs. Clinical Liquid Biopsy
The Market for Liquid Biopsy by Region
The Market for Liquid Biopsy Market by Type of Analyte
The Market for CTC-based Liquid Biopsy
The Market for ctDNA-based Liquid Biopsy
The Market for EV and Exosome-based Liquid Biopsy
The Market for Multi-Analyte-based Liquid Biopsy
The Market for Other Liquid Biopsy
Liquid Biopsy Market by Type of Cancer (Breast, Lung, Colorectal, Ovarian, Prostate, Pan-Cancer, Other Cancer)
Selected ctDNA-based Liquid Biopsy Tests in Development
Selected Market-Available CTC-based Liquid Biopsy Tests, 2021
Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2021

While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:

Early detection and diagnosis / screening

Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown

Therapy personalization and monitoring - by molecular characterization of a patient's disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise

Disease monitoring - to observe disease progression, tumor evolution, residual disease, and early detection of recurrence

Prognosis of disease

Product Code: 21-021b

CHAPTER 1: EXECUTIVE SUMMARY

INTRODUCTION

LIQUID BIOPSY TECHNOLOGIES

INDUSTRY STRUCTURE

LIQUID BIOPSY MARKET REVENUES AND FORECAST
- Figure 1-1: Global Liquid Biopsy Market by Geographic Region, 2021 (%)
- Table 1-1: Global Liquid Biopsy Market Forecast, by Region ($ millions), 2021-2026
- Figure 1-2: Global Liquid Biopsy Market Forecast by Region $ millions), 2021-2026

CHAPTER 2: LIQUID BIOPSY TECHNOLOGIES

INTRODUCTION
- Table 2-1: Comparison of Tissue and Liquid Biopsy

CURRENT MAJOR LIQUID BIOPSY TECHNOLOGIES
- Table 2-2: Advantages and Limitations of Major Liquid Biopsy Technologies

CHAPTER 3: CIRCULATING TUMOR DNA (CTDNA) LIQUID BIOPSY

INTRODUCTION

ADVANTAGES AND LIMITATIONS OF CTDNA IN LIQUID BIOPSY

CURRENT CTDNA-BASED LIQUID BIOPSY TESTS
- Table 3-1: Selected Market-Available ctDNA-based Liquid Biopsy Tests, 2021

Biocartis
Biocept
Biodesix
CellMax Life
Circulogene
Diacarta
Epigenomics
Foundation Medicine (Roche)
Guardant Health
Inivata (Neogenomics)
LungLife AI
Myriad Genetics
NeoGenomics
OncoDNA
Personal Genomic Diagnostics
QIAGEN
Resolution Biosciences
Roche Diagnostics
Sysmex-Inostics
Tempus

CTDNA-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
- Table 3-2: Selected ctDNA-based Liquid Biopsy Tests in Development

Exact Sciences
Freenome
GRAIL
Neogenomics

CHAPTER 4: CIRCULATING TUMOR CELLS (CTCS) LIQUID BIOPSY

INTRODUCTION

CHALLENGES IN THE DEVELOPMENT OF CTC-BASED LIQUID BIOPSY TESTS

CTC-BASED LIQUID BIOPSY TESTS
- Table 4-1: Selected Market-Available CTC-based Liquid Biopsy Tests, 2021

Adaptive Biotechnologies
Biocept
CellMax Life
Epic Sciences
GILUPI
LungLife AI
Menarini-Silicon Biosystems
QIAGEN

CTC-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
- Table 4-2: Selected CTC-based Liquid Biopsy Tests in Development, 2021

ANGLE
Epic Sciences
Liquid Biotech USA

CHAPTER 5: EXTRACELLULAR VESICLES AND OTHER LIQUID BIOPSY

INTRODUCTION

LIQUID BIOPSY TESTS BASED ON EXTRACELLULAR VESICLES / OTHER ANALYTES
- Table 5-1: Selected Market-Available Liquid Biopsy Tests based on Extracellular Vesicles / Other Analytes, 2021

Aspira Women's Health (formerly Vermillion)
Biodesix
Exosome Diagnostics
Hologic
MDxHealth

EXTRACELLULAR VESICLE/OTHER ANALYTE-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
- Table 5-2: Selected Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development, 2021

Circulogene
OncoCyte
Resolution Biosciences
VolitionRx

CHAPTER 6: MULTI-ANALYTE LIQUID BIOPSY TESTS

INTRODUCTION

LIQUID BIOPSY TESTS BASED ON MULTIPLE ANALYTES
- Table 6-1: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2021

Biocept
Biodesix
Foundation Medicine (Roche)
LungLife AI
NeoGenomics
OncoDNA

MULTIPLE ANALYTE-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
- Table 6-2: Selected Multi Analyte-based Liquid Biopsy Tests in Development, 2021

Exact Sciences
Freenome
GRAIL
LungLife AI

CHAPTER 7: LIQUID BIOPSY TESTS FOR RESEARCH USE ONLY

INTRODUCTION

LIQUID BIOPSY TESTS FOR RESEARCH USE ONLY
- Table 7-1: Selected Liquid Biopsy Tests for Research Use Only, 2021

Agena Bioscience
ANGLE
DiaCarta
Exosome Diagnostics
Guardant Health
Natera
QIAGEN

CHAPTER 8: LIQUID BIOPSY INDUSTRY ANALYSIS

INTRODUCTION

TIERS OF COMPETITION
- Table 8-1: Selected Participants in the Liquid Biopsy Market, 2021

COMPETITIVE FACTORS

SIGNIFICANT MARKET TRENDS
- Table 8-2: Significant Trends in the Liquid Biopsy Market, 2021

Personalized Medicine
Increasing Global Life Expectancy
New Liquid Biopsy Products
Increasing Accessibility of Genetic Testing
Regulatory Hurdles
Third-Party Payor Coverage
Demonstrated Clinical Utility
Incidence Rates of Specific Cancers

COMPETITORS NO LONGER IN THE LIQUID BIOPSY MARKET
- Table 8-3: Summary of Companies That Have Exited the Liquid Biopsy Market

CHAPTER 9: LIQUID BIOPSY MARKET

MARKET OVERVIEW
- Figure 9-1: Global Liquid Biopsy Diagnostics Market Estimate by Analyte, 2021 (%)
- Figure 9-2: Global Liquid Biopsy Diagnostics Market Estimate by Region, 2021 (%)
- Figure 9-3: Global Liquid Biopsy Market Estimate by Type of Use, (Research Use, Clinical Diagnostics Use) 2018 (%)

MARKET FORECAST
- Table 9-1: Global Liquid Biopsy Market Forecast by Region - North America, Europe, Asia Pacific, Rest of World, World ($ millions), 2021-2026
- Figure 9-4: Global Liquid Biopsy Market Forecast by Region - North America, Europe, Asia Pacific, Rest of World ( $ millions), 2021-2026

CHAPTER 10: MARKET BY ANALYTE

CIRCULATING TUMOR DNA
- Market Overview
- Applications
- Technologies
- Specimens
- Revenue Forecast
  - Table 10-1: Global Liquid Biopsy Market for ctDNA ($ millions), 2021-2026

CIRCULATING TUMOR CELLS
- Market Overview
- Applications
- Technologies
- Specimens
- Revenue Forecast
  - Table 10-2: Global Liquid Biopsy Market for CTCs ($ millions), 2021-2026

EXTRACELLULAR VESICLES AND OTHER ANALYTES
- Market Overview
- Applications
- Technologies
- Specimens
- Revenue Forecast
  - Table 10-3: Global Liquid Biopsy Market for Extracellular Vesicles ($ millions), 2021-2026

MULTIPLE ANALYTES
- Market Overview
- Revenue Forecast
  - Table 10-4: Global Liquid Biopsy Market for Multiple Analytes ($ millions), 2018-2023

CHAPTER 11: MARKET BY APPLICATION

THERAPY GUIDANCE AND MONITORING
- Market Overview
- Revenue Forecast
  - Table 11-1: Liquid Therapy for Therapy Guidance ($ millions), 2021-2026

DIAGNOSIS/SCREENING
- Market Overview
- Revenue Forecast
  - Table 11-2: Global Liquid Biopsy Market for Diagnosis and Screening ($ millions), 2021-2026

DISEASE PROGNOSIS
- Market Overview
- Revenue Forecast
  - Table 11-3: Global Liquid Biopsy Market for Disease Prognosis ($ millions), 2021-2026

CHAPTER 12: MARKET BY CANCER TYPE

BREAST CANCER
- Market Overview
- Revenue Forecast
  - Table 12-1: Global Liquid Biopsy Market for Breast Cancer ($ millions), 2021-2026

COLORECTAL CANCER
- Market Overview
- Revenue Forecast
  - Table 12-2: Global Liquid Biopsy Market for Colorectal Cancer ($ millions), 2021-2026

LUNG CANCER
- Market Overview
- Revenue Forecast
  - Table 12-3: Global Liquid Biopsy Market for Lung Cancer ($ millions), 2021-2026

OVARIAN CANCER
- Market Overview
- Revenue Forecast
  - Table 12-4: Global Liquid Biopsy Market for Ovarian Cancer ($ millions), 2021-2026

PROSTATE CANCER
- Market Overview
- Revenue Forecast
  - Table 12-5: Global Liquid Biopsy Market for Prostate Cancer ($ millions), 2021-2026

OTHER CANCERS
- Market Overview
- Revenue Forecast
  - Table 12-6: Global Liquid Biopsy Market for Other Cancers ($ millions), 2021-2026

Notes: *Including bladder, gastrointestinal, pancreatic, renal, melanoma and hematological malignancies.

PAN-CANCER TESTS
- Market Overview
- Revenue Forecast
  - Table 12-7: Global Liquid Biopsy Market for Pan-Cancer Testing ($ millions), 2021-2026

CHAPTER 13: LIQUID BIOPSY COMPANY PROFILES

TOP TEN COMPANIES IN THE LIQUID BIOPSY MARKET
- Table 13-1

Top Ten Companies in the Liquid Biopsy Market
- ADAPTIVE BIOTECHNOLOGIES
- AGENA BIOSCIENCE, INC.
- ANGLE, PLC
- ASPIRA WOMEN'S HEALTH
- BIOCARTIS GROUP NV
- BIOCEPT, INC.
- BIODESIX
- CELLMAX LIFE
- CIRCULOGENE
- DIACARTA, INC.
- EPIC SCIENCES
- EPIGENOMICS AG
- EXACT SCIENCES
- EXOSOME DIAGNOSTICS, INC.
- FOUNDATION MEDICINE, INC. (ROCHE)
- FREENOME, INC.
- GILUPI GMBH
- GRAIL (ILLUMINA)
- GUARDANT HEALTH, INC.
- HOLOGIC
- LUNGLIFE AI (FORMERLY CYNVENIO BIOSYSTEMS)
- MDXHEALTH
- MENARINI-SILICON BIOSYSTEMS, SPA
- MYRIAD GENETICS, INC.
- NATERA, INC.
- NEOGENOMICS LABORATORIES, INC.
- ONCOCYTE CORPORATION
- ONCODNA S.A.
- ONCIMMUNE
- PERSONAL GENOME DIAGNOSTICS
- PREDICINEQ2 SOLUTIONSQIAGEN N.V.
- Cell-free DNA Technologies
- CTC Technologies
- Exosome and miRNA Technologies
- RESOLUTION BIOSCIENCES (AGILENT)
- ROCHE DIAGNOSTICS
- STAGEZERO LIFE SCIENCES
- SYSMEX-INOSTICS, INC.
- TEMPUS
- VERACYTE
- VOLITIONRX